An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry)

Completed

Conditions studied: Breast Cancer

In brief

This multi-center, prospective observational study will evaluate the treatment patterns, and the safety in patients with HER2-positive (HER2+) metastatic breast cancer (MBC). Eligible patients will have an initial metastatic breast cancer diagnosis that has not been previously treated with systemic therapy; patients may be enrolled up to 6 months after the diagnosis. Data will be collected for up to 8 years.

Key facts

Study ID

NCT01615068

Run by

Genentech, Inc.

People needed

1007

Starts

2012-06-05

Expected to finish

2017-11-16

Last updated by the study team

2018-07-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients, >/=18 years of age
• Initial diagnosis of HER2+ MBC, as diagnosed by the treating physician, no more than 6 months prior to study enrollment
• Availability of cancer-specific historical data points in the patient's medical records

You may not qualify if…

• Any inability to provide informed consent

Where it is running

• University of South Alabama; Mitchell Cancer Institute — Mobile, Alabama, United States
• Arizona Oncology Associates, PC - NAHOA — Sedona, Arizona, United States
• Arizona Oncology — Tucson, Arizona, United States
• Genesis Cancer Center — Hot Springs, Arkansas, United States
• NEA Baptist Clinic — Jonesboro, Arkansas, United States
• Hematology Oncology Services of Arkansas — Little Rock, Arkansas, United States
• Highlands Oncology Group — Rogers, Arkansas, United States
• East Valley Hem/Onc Med Group; Metropolitan Hem Onc. — Burbank, California, United States
• South Bay Oncology Hematology Partners — Campbell, California, United States
• California Cancer Associates for Research & Excellence, Inc. — Encinitas, California, United States
• ROBERT A. MOSS, M.D., F.A.C.P., Inc — Fountain Valley, California, United States
• California Oncology of the Central Valley — Fresno, California, United States
• Cancer Care Associates — Fresno, California, United States
• St. Jude Heritage Healthcare; Virgiia K.Crosson Can Ctr — Fullerton, California, United States
• University of Southern California — Los Angeles, California, United States
• UCLA School of Medicine — Los Angeles, California, United States
• Comprehensive Cancer Care — Palm Springs, California, United States
• Univ of Calif, San Francisco; Breast Cancer Center — San Francisco, California, United States
• Coastal Integrative Cancer Care — San Luis Obispo, California, United States
• Central Coast Medical Oncology — Santa Maria, California, United States
• Sutter Pacific Medical Foundation — Santa Rosa, California, United States
• Kaiser Permanente Of Colorado — Denver, Colorado, United States
• Rocky Mountain Cancer Center - Denver — Denver, Colorado, United States
• Mile High Oncology — Littleton, Colorado, United States
• St. Vincent'S Hospital; Birmingham Hematology Oncology Associates, Llc — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.